Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse

被引:39
|
作者
Meljon, Anna [1 ]
Wang, Yuqin [1 ]
Griffiths, William J. [1 ]
机构
[1] Swansea Univ, Coll Med, Inst Mass Spectrometry, Swansea SA2 8PP, W Glam, Wales
基金
英国生物技术与生命科学研究理事会;
关键词
24S-Hydroxycholesterol; 24R-Hydroxycholesterol; 24S; 25-Epoxycholesterol; Oxysterol; Brain; Cyp46a1; LIVER X RECEPTORS; MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; METABOLISM; TURNOVER; CELLS; BILE; 24S-HYDROXYCHOLESTEROL; 25-HYDROXYCHOLESTEROL; HOMEOSTASIS;
D O I
10.1016/j.bbrc.2014.01.153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxysterols are oxidised forms of cholesterol or its precursors. In this study we utilised the cholesterol 24-hydroxylase knockout mouse (Cyp46a1-/-) to study the sterol and oxysterol content of brain. Despite a great reduction in the abundance of 24S-hydroxycholesterol, the dominant metabolite of cholesterol in wild type brain, no other cholesterol metabolite was found to quantitatively replace this oxysterol in the Cyp46a1-/- mouse. Only minor amounts of other side-chain oxysterols including 22R-, 24R-, 25- and (25R),26-hydroxycholesterols were detected. In line with earlier studies, levels of cholesterol were similar in Cyp46a1-/- and wild type animals. However, the level of the cholesterol precursor, desomsterol, and its parallel metabolite formed via a shut of the mevalonate pathway, 24S,25-epoxycholesterol, were reduced in the Cyp46a1-/- mouse. The reduction in abundance of 24S,25-epoxycholesterol is interesting in light of a recent report indicating that this oxysterol promotes dopaminergic neurogenesis. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
引用
收藏
页码:768 / 774
页数:7
相关论文
共 50 条
  • [31] Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease
    Desai, P
    DeKosky, ST
    Kamboh, MI
    NEUROSCIENCE LETTERS, 2002, 328 (01) : 9 - 12
  • [32] 24-hydroxylase Is Downregulated in Patients with Cushing's Disease
    Povaliaeva, Alexandra
    Zhukov, Artem
    Bogdanov, Viktor
    Pigarova, Ekaterina
    Dzeranova, Larisa
    Rozhinskaya, Liudmila
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 199 - 199
  • [33] High Cholesterol Diet Increases Expression of Cholesterol 24-Hydroxylase and BACE1 in Rat Hippocampi: Implications for the Effect of Diet Cholesterol on Memory
    Nikasa, Mitra
    Karimi, Pouran
    Rajavand, Hosnieh
    Afshari, Fatemeh
    Jafarlou, Mahdi
    Soltanali, Mahboob
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (12)
  • [34] The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson's disease
    Dai, Lijun
    Wang, Jiannan
    Meng, Lanxia
    Zhang, Xingyu
    Xiao, Tingting
    Deng, Min
    Chen, Guiqin
    Xiong, Jing
    Ke, Wei
    Hong, Zhengyuan
    Bu, Lihong
    Zhang, Zhentao
    PLOS BIOLOGY, 2025, 23 (02)
  • [35] Brain Cholesterol Metabolism, Oxysterols, and Dementia
    Hughes, Timothy M.
    Rosano, Caterina
    Evans, Rhobert W.
    Kuller, Lewis H.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (04) : 891 - 911
  • [36] Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism
    Yutuc, Eylan
    Angelini, Roberto
    Baumert, Mark
    Mast, Natalia
    Pikuleva, Irina
    Newton, Jillian
    Clench, Malcolm R.
    Skibinski, David O. F.
    Howell, Owain W.
    Wang, Yuqin
    Griffiths, William J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (11) : 5749 - 5760
  • [37] Loss of 24-Hydroxylase in Murine Fetuses Causes Hypercalcemia and Hypophosphatemia
    Bennin, David
    Hartery, Sarah A.
    Maekawa, Alexandre S.
    Kirby, Beth J.
    St-Arnaud, Rene
    Kovacs, Christopher S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 125 - 125
  • [38] Evaluation of pharmacodynamic effects of cholesterol 24-hydroxylase inhibitor TAK-935 and its target engagement in animals
    Koike, Tatsuki
    Miyamoto, Maki
    Nishi, Toshiya
    Sunahara, Eiji
    Hasegawa, Shigeo
    Watanabe, Sayuri
    Ikeda, Shuhei
    Ishii, Tsuyoshi
    Kondo, Shinichi
    Takahashi, Junzo
    Hirabayashi, Hideki
    Alagille, David
    Barret, Olivier
    Tamagnan, Gilles
    Kuroita, Takanobu
    NEUROLOGY, 2018, 90
  • [39] AAV Gene Therapy with Cholesterol 24-Hydroxylase for Alzheimer Disease: In Vivo Consequences on Amyloid and Tau Components of the Pathology
    Gautier, Benoit
    Burlot, Marie Anne
    Blum, David
    Hudry, Eloise
    Ayciriex, Sophie
    Troquier, L.
    Zommer, N.
    Caillerez, R.
    Auzeil, Vincent
    Braudeau, Jerome
    Laprevote, Olivier
    Pradier, Laurent
    Aubourg, Patrick
    Buee, Luc
    Cartier, Nathalie
    MOLECULAR THERAPY, 2012, 20 : S30 - S31
  • [40] Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease
    Ingelsson, M
    Jesneck, J
    Irizarry, MC
    Hyman, BT
    Rebeck, GW
    NEUROSCIENCE LETTERS, 2004, 367 (02) : 228 - 231